A carregar...
Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region
Lung cancer remains a major cause of cancer mortality with a 5-year survival in advanced stages around 4%. Platinum-based chemotherapy was routinely used as the standard of care in patients with advanced nonsmall cell lung cancer, but it is being progressively replaced by targeted molecular therapy....
Na minha lista:
| Publicado no: | Ann Thorac Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611202/ https://ncbi.nlm.nih.gov/pubmed/31333766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_344_18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|